Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
AbbVie rolls up another big win for elagolix as the prospective blockbuster sweeps endpoints in latest PhIII
Endpoints
Wed, 02/21/18 - 09:36 am
AbbVie
Elagolix
endometriosis
uterine fibroids
With $69M Deal, AbbVie Turns to Voyager for an Alzheimer’s Gene Therapy
Xconomy
Tue, 02/20/18 - 10:58 pm
AbbVie
Voyager Therapeutics
gene therapy
Alzheimer's disease
AbbVie Presents New Data on Upadacitinib for Crohn's Disease
Yahoo/Zacks.com
Mon, 02/19/18 - 04:18 pm
AbbVie
Upadacitinib
Crohn's Disease
AbbVie, Allergan, Roche could join Biogen, UCB in Acorda hunt: analyst
Fierce Pharma
Fri, 02/16/18 - 09:38 pm
AbbVie
Allergan
Roche
Biogen
UCB Pharma
Acorda Therapeutics
M&A
Top 10 most productive workforces in biopharma
Fierce Pharma
Mon, 02/12/18 - 11:03 am
Pharma
pharma employees
productivity
Gilead Sciences
Celgene
Pfizer
AbbVie
Biogen
These 3 Drugs Are Critical to AbbVie's Success
Motley Fool
Mon, 02/12/18 - 09:10 am
AbbVie
Rova-T
Upadacitinib
risankizumab
Watch These Biotechs and the FDA Calendar
TheStreet.com
Sun, 02/11/18 - 01:23 pm
FDA
biotech
Dynavax
HEPLISAV-B
Progenics
Azedra
Neurocrine
Elagolix
AbbVie
ABBV to Focus on Advancing Late-Stage Immunology Research in 2018
Market Realist
Thu, 02/8/18 - 11:17 am
AbbVie
R&D
immunology
Upadacitinib
risankizumab
Dogged by AbbVie's new share-stealing Mavyret, Gilead's hep C forecast comes in far short
Fierce Pharma
Thu, 02/8/18 - 09:14 am
AbbVie
Mavyret
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
AbbVie, Pfizer in another close TV ad spending race to kick off 2018
Fierce Pharma
Wed, 02/7/18 - 10:02 am
AbbVie
Pfizer
drug ads
television ads
Biopharma in charts: Key takeaways from Q4 earnings
Biopharma Dive
Mon, 02/5/18 - 12:35 pm
earnings
Merck
JNJ
AbbVie
Roche
Celgene
Eli Lilly
3 Big Biotech Stocks With Major Catalysts on the Way
Motley Fool
Tue, 01/30/18 - 09:50 am
biotech
AbbVie
Neurocrine Biosciences
Elagolix
Celgene
ozanimod
Gilead Sciences
bictegravir
Why big pharma companies always create new spinoffs
GoinPharma
Sun, 01/28/18 - 10:06 am
spinoffs
Sanofi
Celgene
Biogen
AbbVie
Abbott Labs
Baxalta
Shire
AbbVie wins U.S. trial in lawsuit over AndroGel's risks
Yahoo/Reuters
Sat, 01/27/18 - 09:38 am
AbbVie
Androgel
pulmonary embolism
Why AbbVie (ABBV) Might Surprise This Earnings Season
Yahoo/Zacks.com
Thu, 01/25/18 - 09:33 am
AbbVie
earnings
5 Highest-Growth Drugs of 2018 -- and Who Will Get Rich from Them
Motley Fool
Sun, 01/21/18 - 10:53 am
Merck
Keytruda
AbbVie
Humira
Mavyret
Bristol-Myers Squibb
Eliquis
Pfizer
Ibrance
Novartis aims for US approval of Humira biosimilar
Biopharma Dive
Wed, 01/17/18 - 09:55 pm
Novartis
Humira
biosimilars
AbbVie
Sandoz
Why AbbVie's Upadacitinib Keeps Posting Strong Data for Rheumatoid Arthritis
Market Realist
Mon, 01/8/18 - 09:42 am
AbbVie
Upadacitinib
rheumatoid arthritis
2018 Healthcare And Biotech Outlook
Seeking Alpha
Sun, 01/7/18 - 12:41 pm
AbbVie
Abbott Labs
Amgen
Allergan
AstraZeneca
Gilead Sciences
Bristol-Myers Squibb
5 Biggest New Drugs of 2018
Motley Fool
Sun, 01/7/18 - 12:35 pm
Gilead Sciences
Bictegravir/F/TAF
Novo Nordisk
semaglutide
Ozempic
Incyte
epacadostat
AbbVie
Rova-T
Celgene
ozanimod
Pages
« first
‹ previous
…
37
38
39
40
41
42
43
44
45
…
next ›
last »